CLINICAL_TRIALS
trial_result
· 2022-07-07
Clinical Trial Update: ENDOTHELION Study Group: Effect of Bosentan in NAION Patients [Phase 3]
Summary
Phase 3 trial evaluating bosentan in ischemic optic neuropathy is ongoing with undisclosed status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Grenoble | Conditions: Ischemic Optic Neuropathy | Phase 3 | Status: UNKNOWN